23 results
10-K
2023 FY
TSBX
Turnstone Biologics Corp
21 Mar 24
Annual report
8:51pm
” initiates and takes responsibility for a clinical investigation. A person who both initiates and conducts a clinical trial, and is responsible for all … the study drug is administered or dispensed to patients. A “sponsor” initiates and takes responsibility for a clinical investigation. A person who both
10-Q
2023 Q2
TSBX
Turnstone Biologics Corp
1 Sep 23
Quarterly report
4:39pm
agency’s agreed upon pediatric investigation plan. The exclusivity period in the EU can be reduced to six years if at the end of the fifth year a drug
8-K
EX-3.2
v1ycrqq
25 Jul 23
Amendments to Articles of Incorporation or Bylaws
4:15pm
424B4
cu8 yjnhqe0
21 Jul 23
Prospectus supplement with pricing info
7:14pm
S-1/A
rnr ifpwitlozur3
23 Jun 23
IPO registration (amended)
9:49pm
S-1/A
EX-10.6
no422si0jl4mmevkc 5s
23 Jun 23
IPO registration (amended)
9:49pm
S-1/A
EX-3.4
xdwsf2s
23 Jun 23
IPO registration (amended)
9:49pm
S-1
EX-2.1
87ggqsv1baq
12 Jun 23
IPO registration
4:28pm
S-1
b2puc
12 Jun 23
IPO registration
4:28pm
S-1
EX-3.2
4s1l8vvsrf6n
12 Jun 23
IPO registration
4:28pm
S-1
EX-10.9
4tp6qztt
12 Jun 23
IPO registration
4:28pm
S-1
EX-10.8
syjmbzwpiqcet
12 Jun 23
IPO registration
4:28pm
S-1
EX-4.2
0w8z japev00vr394hf7
12 Jun 23
IPO registration
4:28pm
DRS
EX-3.2
l2otn
15 May 23
Draft registration statement
12:00am
DRS
EX-10.8
0u1gxv4iaf9y311 p2
15 May 23
Draft registration statement
12:00am